ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients

被引:3
|
作者
Liu, Dingxie [1 ]
Hao, Qiongyu [2 ,3 ]
Li, Jieqing [2 ,3 ,4 ,5 ]
Li, Qun [6 ]
Wang, Kun [4 ,5 ]
Geng, Qing [7 ]
Wu, Yutong [1 ]
Vadgama, Jaydutt V. [2 ,3 ]
Wu, Yong [2 ,3 ]
机构
[1] Bluewater Biotech LLC, POB 1010, New Providence, NJ 07974 USA
[2] Charles Drew Univ Med & Sci, David Geffen UCLA Sch Med, Dept Internal Med, Div Canc Res & Training, Los Angeles, CA 90095 USA
[3] UCLA Jonsson Comprehens Canc Ctr, 1748 E 118th St, Los Angeles, CA 90095 USA
[4] Guangdong Prov Peoples Hosp, Canc Ctr, Dept Breast Canc, Guangzhou 510080, Guangdong, Peoples R China
[5] Guangdong Acad Med Sci, Guangzhou 510080, Guangdong, Peoples R China
[6] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Oncol, Shanghai 200123, Peoples R China
[7] Wuhan Univ, Dept Thorac Surg, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China
关键词
D O I
10.1002/cac2.12296
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:663 / 667
页数:5
相关论文
共 50 条
  • [31] A new hormonal therapy for estrogen receptor-negative breast cancer
    Hardin, Chelsea
    Pommier, Rodney
    Calhoun, Kristine
    Muller, Patrick
    Jackson, Terisa
    Pommier, SuEllen
    WORLD JOURNAL OF SURGERY, 2007, 31 (05) : 1041 - 1046
  • [32] Estrogen-Related Receptor a Is Critical for the Growth of Estrogen Receptor-Negative Breast Cancer
    Stein, Rebecca A.
    Chang, Ching-yi
    Kazmin, Dmitri A.
    Way, James
    Schroeder, Thies
    Wergin, Melanie
    Dewhirst, Mark W.
    McDonnell, Donald P.
    CANCER RESEARCH, 2008, 68 (21) : 8805 - 8812
  • [33] An estrogen receptor-negative breast cancer subset with over expression of hormone responsive genes
    Doane, AS
    Danso, MA
    Lal, P
    Donaton, M
    Zhang, L
    Hudis, C
    Gerald, WL
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S18 - S18
  • [34] Molecular dependence of estrogen receptor-negative breast cancer on a Notch-survivin signaling axis
    Lee, Connie W.
    Raskett, Christopher M.
    Prudovsky, Igor
    Altieri, Dario C.
    CANCER RESEARCH, 2008, 68 (13) : 5273 - 5281
  • [35] Vitamin D induces expression of estrogen receptor and restores endocrine therapy response in estrogen receptor-negative breast cancer
    Santos, N.
    Diaz, L.
    Ordaz, D.
    Garcia, J.
    Barrera, D.
    Avila, E.
    Halhali, A.
    Medina, H.
    Camacho, J.
    Larrea, F.
    Garcia, R.
    CANCER RESEARCH, 2012, 72
  • [36] Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
    Niemeier, Leo A.
    Dabbs, David J.
    Beriwal, Sushil
    Striebel, Joan M.
    Bhargava, Rohit
    MODERN PATHOLOGY, 2010, 23 (02) : 205 - 212
  • [37] The Hedgehog Pathway Is a Possible Therapeutic Target for Patients with Estrogen Receptor-negative Breast Cancer
    Kameda, Chizu
    Tanaka, Haruo
    Yamasaki, Akio
    Nakamura, Masafumi
    Koga, Kenichiro
    Sato, Norihiro
    Kubo, Makoto
    Kuroki, Syoji
    Tanaka, Masao
    Katano, Mitsuo
    ANTICANCER RESEARCH, 2009, 29 (03) : 871 - 879
  • [38] The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy
    Zhang, Shu
    Lei, Ping
    Liu, Xinyi
    Li, Xiangrong
    Walker, Kelcey
    Kotha, Leela
    Rowlands, Craig
    Safe, Stephen
    ENDOCRINE-RELATED CANCER, 2009, 16 (03) : 835 - 844
  • [39] Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    HUMAN PATHOLOGY, 2015, 46 (11) : 1776 - 1784
  • [40] Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer
    Lipsey, Crystal C.
    Harbuzariu, Adriana
    Robey, Robert W.
    Huff, Lyn M.
    Gottesman, Michael M.
    Gonzalez-Perez, Ruben R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11)